World Equity Group, Inc. Summit Therapeutics Inc. Transaction History
World Equity Group, Inc.
- $277 Billion
- Q3 2024
A detailed history of World Equity Group, Inc. transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, World Equity Group, Inc. holds 14,842 shares of SMMT stock, worth $310,049. This represents 0.12% of its overall portfolio holdings.
Number of Shares
14,842
Previous 12,779
16.14%
Holding current value
$310,049
Previous $99.7 Million
226.1%
% of portfolio
0.12%
Previous 0.03%
Shares
3 transactions
Others Institutions Holding SMMT
# of Institutions
148Shares Held
66.2MCall Options Held
1.05MPut Options Held
1.02M-
Baker Bros. Advisors LP New York, NY23.2MShares$485 Million2.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.82MShares$184 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$165 Million0.0% of portfolio
-
State Street Corp Boston, MA4.12MShares$86.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.96MShares$61.9 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $4.2B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...